Andrew L. Gilman

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee et al. · Biology of Blood and Marrow Transplantation · 2006 · 565 citations · Full text

Life Sciences, Immunology, Clinical Immunology +12

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · Clinical Cancer Research · 2021 · 216 citations · Full text

Life Sciences, Immunology, Oncology +17

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Celalettin Üstün, Andreas Reiter, Bart L. Scott et al. · Journal of Clinical Oncology · 2014 · 185 citations · Full text

Medicine, Hematology, Immunology +17

Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties

Frederick D. Goldman, Andrew L. Gilman, Clay Hollenback et al. · Blood · 2000 · 177 citations

Life Sciences, Immunology, Pharmacology +17